• DOI:10.1258/136218006775992185
Corpus ID: 38095916

Hormone replacement therapy with estradiol and drospirenone: An overview of the clinical data

@article{Whitehead2006HormoneRT,
  title={Hormone replacement therapy with estradiol and drospirenone: An overview of the clinical data},
  author={M. Whitehead},
  journal={Post Reproductive Health},
  year={2006},
  volume={12},
  pages={4 - 7}
}

• M. Whitehead
• Published 2006
• Medicine
• Post Reproductive Health

A new form of continuous combined hormone replacement therapy has become available that contains estradiol and drospirenone as the progestogen component. Drospirenone is a synthetic progestogen, the only one in hormone replacement therapy in the UK that possesses clinically relevant anti-mineralocorticoid activity. The combination of estradiol and drospirenone has been shown to provide relief from estrogen-deficiency symptoms of the menopause. It also helps to prevent osteoporosis in… Expand